Navigation Links
Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
Date:3/18/2008

CAMBRIDGE, Mass., March 18 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced that it has completed its first clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.

The Phase I single ascending dose, double blind placebo controlled randomized study involved 56 healthy volunteers who received the drug in eight escalating dose cohorts. All doses were safe and well tolerated, and there were no serious adverse events. Pharmacodynamic assays demonstrated evidence of immune exposure consistent with the pharmacologic mechanism of action for PI-2301, and dose related pharmacokinetics were observed. The Company plans to initiate its first repeat dose study in multiple sclerosis patients in Q2/2008.

"We are pleased to see that PI-2301 was well tolerated and that this trial has provided evidence of single dose priming of healthy subjects. This effect is important as repeated doses in multiple sclerosis patients should lead to therapeutic immune modulation," stated Thomas P. Mathers, President and CEO of Peptimmune. "We have designed PI-2301 to maximize the therapeutic benefit of a proven, safe compound class in multiple sclerosis as well as increasing patients' convenience."

PI-2301 is a second generation peptide copolymer from a similar compound class as Copaxone(R) (Teva Pharmaceuticals). PI-2301 works through immune modulation by enhancing the regulatory response of the immune system to control the pathogenic autoimmune response in certain diseases. PI-2301 has been optimized using Peptimmune's novel platform peptide chemistry and in pre- clinical studies, has shown to be more potent and effective than Copaxone in treating disease models for multiple sclerosis. PI-2301 has also shown efficacy in pre-clinical models of autoimmune diseases where immune modulation may be effe
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine technology :

1. Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
2. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
3. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
4. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
5. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
6. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
7. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
8. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
9. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
10. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
11. Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Medical Oxygen Systems -...eportlinker.com/p0164334/Medical-Oxygen-Systems---...medical oxygen systems market for home healthcare .... The buoyant growth expectations stem from demogr...
(Date:12/1/2009)...UE, Wash., Dec. 1 drugst...etailer of health, beauty, vision, and pharmacy pr...best day ever as customer orders were the highest ...tore.com and Beauty.com web stores featured mor...largest gift selection yet. ,, (Logo: http://w...
(Date:12/1/2009)...RK, Dec. 1 Reportlinker.com announ... in its catalogue: ,, Latin American Pharmace... market analysis, forecasts and growth opportuniti...Latin-American-Pharmaceutical-Market-Outlook-To-20...d-growth-opportunities.html ,, The $28.8bn L...
Breaking Medicine Technology:Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8ISMPP Supports Best Practices and Transparency in Medical Publications 3A Better Understanding of Terms Such as Ghostwriting Needed 14486 1ISMPP Supports Best Practices and Transparency in Medical Publications 3A Better Understanding of Terms Such as Ghostwriting Needed 14486 2ISMPP Supports Best Practices and Transparency in Medical Publications 3A Better Understanding of Terms Such as Ghostwriting Needed 14486 3AmeriCares Honors Cardinal Health with Power of Partnership Award 5515 1AmeriCares Honors Cardinal Health with Power of Partnership Award 5515 2AmeriCares Honors Cardinal Health with Power of Partnership Award 5515 3Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over Allotment Option 5511 1Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over Allotment Option 5511 2
(Date:12/1/2009)... -- Reportlinker.com announces that a new market r..., Emerging Clinical Trial Locations - India: Mar...atory environment ,, http://www.reportlinker...India-Market-dynamics-and-the-changing-healthcare-...st decade pharmaceutical and biotechnology compani...
(Date:12/1/2009)...ire/ -- As health care reform takes the national s...re delivery model, renowned entrepreneur Henry J. ...Hall of Fame. Kaiser,s eldest granddaughter, Carly...ia medal on his behalf during a formal, private st...iser,s greatest legacy is Kaiser Permanente, one o...
(Date:12/1/2009)...e easily identified, study finds , , TUE...ance imaging test is highly effective at detecting...placenta accreta, researchers report. , The con...s attaches too deeply to a woman,s uterus. During ...terine wall, rupturing blood vessels and putting t...
(Date:12/1/2009)...e-USNewswire/ -- The American Society of Hematolog...ymposium at the New Orleans Marriott on Thursday, ... encourages an interest in hematology, the biologi...junction with the Society,s 51st Annual Meeting. T...plore research on sickle cell disease, an inherite...
(Date:12/1/2009)...re/ -- A national survey reveals the majority of m...s and themselves but at the same time want the rig...milies. ,, See video from HealthyWomen at: htt...of mothers of children aged 12 months and younger ...eding decision prior to going to the hospital to g...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 2Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 3Health News:Serious Pregnancy Complication Detected With MRI 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2
...rs say health professionals and patients require e... the risks associated with over the counter drugs....e of the most common condition that people choose ...n, coughs, colds, and acid stomach. The report ...
...y occurring radioactive gas// without odour, colou...t emanates from the ground into the air. Radon gas...n depending on the highly variable uranium content...lectrically charged and attach to aerosols, dust a...
...ording to the research finding published by the Am...een found that calorie intake may not be a major f...inding was based on a 17-year study of almost 9,79...rticipants were grouped based on reports of calori...
...levels of children exposed to the epilepsy drug in...ere not exposed to the drug.// The study was co...16 who were born to mothers with epilepsy and test...oic acid during pregnancy had an average verbal IQ...
...he next food enlisted in breast cancer prevention,...dy conducted at the University of California. In t...aweed effectively reduced levels of estradiol, // ... good sign when it comes to preventing breast canc...
...ncer – melanoma ,however researchers as the number...s the number of patients surviving the disease. //...ficial influence on some kinds of cancer. In a stu... of sun exposure were less likely to die. Non-H...
Other Medicine News:Health News:WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: